A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis | Zendy

V. Ramesh | Zendy; Joginder Kumar | Zendy; Dhiraj Kumar | Zendy; Poonam Salotra | Zendy

Open Access

A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis

Author(s) -

V. Ramesh,

Joginder Kumar,

Dhiraj Kumar,

Poonam Salotra

Publication year - 2010

Publication title -

indian journal of dermatology venereology and leprology

Language(s) - English

Resource type - Journals

eISSN - 0973-3922

pISSN - 0378-6323

DOI - 10.4103/0378-6323.60553

Subject(s) - sodium stibogluconate , allopurinol , medicine , rifampicin , cutaneous leishmaniasis , erythema , leishmaniasis , dermatology , surgery , gastroenterology , tuberculosis , immunology , pathology

A retrospective analysis of treatment outcome using recommended dose of sodium stibogluconate (SSG) alone and in combination with other antileishmanial drugs in adults with post-kala-azar dermal leishmaniasis (PKDL) attending as outpatients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog